The Importance of Nutritional Management in GLP-1 Receptor Agonists Therapy
The use of glucagon-like peptide-1 receptor agonists (GLP-1) has revolutionized the treatment of type 2 diabetes and obesity. Medications such as semaglutide, liraglutide, and dulaglutide offer dual benefits of glycemic control and weight loss through mechanisms that include enhanced insulin secretion, suppressed glucagon release, delayed gastric emptying, and reduced appetite [1]. However, while the pharmacologic […]
The Importance of Nutritional Management in GLP-1 Receptor Agonists Therapy Read More »